Recombinant IL6 (Olokizumab Biosimilar) antibody
The Humanized Chimeric anti-IL6 (Olokizumab Biosimilar) antibody is suitable to detect IL6 (Olokizumab Biosimilar) in samples from Human.
Catalog No. ABIN7597873
-15% Promotion 2026
$376.18
save $66.38 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant IL6 (Olokizumab Biosimilar) antibody (ABIN7597873)
Target
IL6 (Olokizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This IL6 (Olokizumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Olokizumab Biosimilar Antibody
-
Specificity
- Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- IL6 (Olokizumab Biosimilar)
-
Alternative Name
- Olokizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor
-
UniProt
- P05231
-
CAS-No
- 1007223-17-7
Target
-
You are here:
